US Stock MarketDetailed Quotes

SYRE Spyre Therapeutics

Watchlist

32.370
+0.890+2.83%

Close Oct 16 16:00 ET

32.370
0.0000.00%

Post 16:20 ET

1.65BMarket Cap2.97P/E (TTM)

Spyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Spyre Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 2.625M	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	0.000 / 2.857M	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 220.000K	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 2.625M--

--2024/Q3-- / 0.000--

--2024/Q20.000 / 2.857M--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 220.000K--

Unlock Free Earnings Estimates

Open Account

Spyre Therapeutics Earnings Reports

Spyre Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 7 16:12 ET

Spyre Therapeutics | 10-Q: Q1 2024 Earnings Report

May 9 16:16 ET

Spyre Therapeutics | 10-K/A: Annual report (Amendment)

Mar 1 06:19 ET

Spyre Therapeutics | 10-K: FY2023 Annual Report

Feb 29 09:04 ET

Analyst Rating

Updated: Oct 15, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall